Product ID |
Product Name |
CAS# |
Purity |
Y3139436 |
3-methanesulfonylcyclopentan-1-one |
1491178-97-2 |
95% |
Y3139453 |
spiro[3.3]heptane-1-carboxylicacid |
1314960-17-2 |
95% |
Y3139441 |
tert-butyl 3,10-diazabicyclo[4.3.1]decane-10-carboxylate, Mixture of diastereomers |
1515348-08-9 |
95% |
Y1335074 |
3-(4-Bromo-1h-pyrazol-1-yl)benzaldehyde |
1341697-43-5 |
98% |
Y3139433 |
4-amino-1-[(1R,3R,4S,7R)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-1,2-dihydropyrimidin-2-one |
32830-01-6 |
95% |
Y3139435 |
2-methyl-1,2,3,4-tetrahydroisoquinoline-6-carboxylicacidhydrochloride |
1065066-61-6 |
95% |
Y3103609 |
2-(4-(Dibenzo[b,d]furan-4-yl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
1056113-44-0 |
97% |
Y3133919 |
2-(oxetan-3-yl)ethyl4-methylbenzene-1-sulfonate |
1135039-66-5 |
95% |
Y3133907 |
5,7-dichloro-1,3-dimethyl-1H-pyrazolo[4,3-d]pyrimidine |
928767-13-9 |
95% |
Y3133929 |
1-(adamantan-1-yl)-2-chloroethan-1-one |
23532-68-5 |
95% |
Y3133910 |
5-benzyl-1,2-oxazol-4-amine hydrochloride |
2375270-77-0 |
95% |
Y3133909 |
2-(dimethylamino)-3,3-dimethylbutanoic acid |
170941-89-6 |
95% |
Y3134327 |
7-bromo-3-methyl-1-benzothiophene-2-carboxylic acid |
1098354-02-9 |
95% |
Y3134010 |
3-bromo-4-methoxypyridine-2-carbonitrile |
1805248-80-9 |
95% |
Y3314156 |
GNF2133 hydrochloride |
2561414-57-9 |
98% |
Y3306787 |
Compound 1T-0219 (SC) |
383147-92-0 |
95% |
Y3311100 |
N-[(E)-({3-[(E)-(carbamimidamidoimino)methyl]phenyl}methylidene)amino]guanidinedihydrochloride |
181147-28-4 |
99% |
Y3293652 |
WNK-IN-11 D3 |
2123483-49-6 |
99% |
Y3318775 |
Xanthalin |
21800-48-6 |
98% |
Y3286522 |
VU6010572 |
2126784-39-0 |
99% |
Y3292072 |
1-[(4-{5-[3-chloro-4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl}phenyl)methyl]-4-[(2-methoxyethoxy)methyl]piperidine-4-carboxylic acid |
1403232-33-6 |
99% |
Y3309610 |
UCB-6876 |
637324-45-9 |
99% |
Y3307030 |
(2E,2'E)-Upenazime |
759443-00-0 |
99% |
Y3310746 |
Upacicalcet |
1333218-50-0 |
100% |
Y3296625 |
TFMB-(S)-2-HG |
1445703-64-9 |
99% |
Y3292143 |
Tenofovir amibufenamide |
1571076-26-0 |
99% |
Y3305398 |
T-0509 |
96843-99-1 |
100% |
Y3305804 |
STAT3-IN-B9 |
825611-06-1 |
98% |
Y3289029 |
N4-(2,6-Dichlorobenzyl)-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine |
1196994-11-2 |
98% |
Y3306516 |
SP-8356 |
1454885-45-0 |
98% |
Y3307558 |
ß-Aminoarteether |
133162-24-0 |
96% |
Y3136993 |
tri-GalNAc-COOH |
1953146-81-0 |
98% |
Y3290888 |
S-777469 |
885496-53-7 |
98% |
Y3292245 |
S116836 |
1257628-57-1 |
99% |
Y3309707 |
RJW100 |
1276664-20-0 |
99% |
Y3291654 |
Mavodelpar |
1604815-32-8 |
99% |
Y3306313 |
Prinomide tromethamine |
109636-76-2 |
100% |
Y3293827 |
Plazinemdor |
2378285-59-5 |
98% |
Y3144094 |
POMHEX |
2004714-34-3 |
99% |
Y3144148 |
6,7-dimethoxy-2-[(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)methyl]-3,4-dihydroquinazolin-4-one |
785708-33-0 |
95% |
Y3144342 |
Pafolacianine |
1628423-76-6 |
98% |
Y3307988 |
Ot-730 |
870809-51-1 |
99% |
Y3305895 |
Orilotimod potassium |
960155-19-5 |
100% |
Y3309595 |
Opiranserin hydrochloride |
1440796-75-7 |
95% |
Y3285831 |
NITD-688 |
2407227-31-8 |
99% |
Y3305918 |
NGD-8243 |
573678-04-3 |
95% |
Y3317808 |
NC1 |
445406-82-6 |
95% |
Y3287918 |
NCT-506 |
2231098-99-8 |
99% |
Y3297895 |
Mito-TRFS |
1859102-62-7 |
95% |
Y3296866 |
MI-389 |
2222635-92-7 |
99% |
Y3144400 |
Milategrast |
859217-52-0 |
98.53% |
Y3287665 |
PRL-3 Inhibitor 2 |
577962-95-9 |
98% |
Y3311600 |
Lobuprofen |
98207-12-6 |
99% |
Y3306384 |
LCB 03-0110 |
1228102-01-9 |
98% |
Y3298149 |
LCAHA |
117094-40-3 |
98% |
Y3292257 |
IW927 |
389142-48-7 |
99% |
Y3151427 |
N-(3-(1H-Imidazol-1-yl)propyl)-5-(thiophen-2-yl)isoxazole-3-carboxamide |
909207-35-8 |
98% |
Y3144403 |
ITF 3756 |
2247608-27-9 |
98.55% |
Y3137168 |
Inupadenant hydrochloride |
2411004-22-1 |
99.60% |
Y3306034 |
IDD388 |
314297-26-2 |
99% |
Y3298042 |
Ilunocitinib |
1187594-14-4 |
98% |
Y3310653 |
ICL-CCIC-0019 |
936498-64-5 |
97% |
Y3305845 |
IFB-088 acetate |
469866-31-7 |
95% |
Y3137181 |
Honokiol DCA |
1620160-42-0 |
95.21% |
Y3308629 |
HDAC8-IN-20a |
1884231-52-0 |
98% |
Y3137209 |
1-(5-chloro-2-methylphenyl)-3-(2-methylpropyl)thiourea |
147751-31-3 |
95% |
Y3294602 |
Gunagratinib |
2211082-53-8 |
99% |
Y3306468 |
GSK572A |
1403602-32-3 |
99% |
Y3288949 |
GNE-149 |
1953132-75-6 |
99% |
Y3307996 |
GS-9191 |
859209-84-0 |
98% |
Y3310627 |
GJ071 oxalate |
1216676-34-4 |
100% |
Y3137210 |
Gemnelatinib |
2225123-30-6 |
99% |
Y3294684 |
Aurora kinase inhibitor-8 |
2133001-88-2 |
98% |
Y3311997 |
Roflupram |
1093412-18-0 |
99% |
Y3287019 |
3-(2-Fluoroethyl)-tricyclo[3.3.1.13,7]decan-1-amine Hydrochloride |
1639210-25-5 |
98% |
Y3306538 |
FK-330 dihydrate |
682813-92-9 |
97% |
Y3311589 |
EN3356 |
1429329-63-4 |
97% |
Y3130376 |
Ebaresdax |
1334471-39-4 |
99% |
Y3311237 |
Donetidine |
99248-32-5 |
99% |
Y3309331 |
Diproteverine HCl |
69373-88-2 |
99% |
Y3306281 |
DDRI-18 |
4402-18-0 |
95% |
Y3130379 |
DC07090 Dihydrochloride |
1158264-37-9 |
99% |
Y3130380 |
({bis[2-(tetradecanoyloxy)ethyl]carbamoyl}methyl)trimethylazaniumchloride |
107086-76-0 |
95% |
Y3131623 |
CPUY192018 |
1567836-15-0 |
98.99% |
Y3285702 |
CaV1.3 antagonist-1 |
1391385-57-1 |
98% |
Y3308794 |
c-Kit-IN-3 |
2363169-01-9 |
99% |
Y3309385 |
CID-663143 |
578723-96-3 |
99% |
Y3310649 |
CB29 |
315239-63-5 |
99% |
Y3131622 |
CC214-2 |
1228012-18-7 |
98% |
Y3294419 |
CC260 |
2411088-26-9 |
99% |
Y3131789 |
BSJ-04-132 |
2349356-39-2 |
98% |
Y3305593 |
BRD4097 |
1550053-19-4 |
99% |
Y3289423 |
BN-82685 |
477603-18-2 |
95% |
Y3298069 |
BCL6-IN-7 |
2097518-46-0 |
99% |
Y3288877 |
BC-23 |
6298-15-3 |
97% |
Y3131788 |
Atuzabrutinib |
1581714-49-9 |
95% |
Y3290544 |
AQX-435 |
1619983-52-6 |
99% |
Y3309836 |
Argipressin acetate (113-79-1(free base)) |
83968-48-3 |
98% |
Y3289280 |
AMXT-1501 |
441022-64-6 |
98% |
Y3292446 |
ALW-II-49-7 |
1135219-23-6 |
99% |